Biocure technology inc
WebMar 15, 2024 · BIOCURE TECHNOLOGY INC. The following management's discussion and analysis ("MD&A") is a review of operations, current financial position and outlook for the … WebMay 31, 2024 · BioCure Technology Inc. (CSE:CURE) (“BioCure” or the “Company”) has issued an aggregate of 1.89 million share purchase warrants with an exercise price of $0.63 per share. The warrants are ...
Biocure technology inc
Did you know?
WebApr 12, 2024 · Bid and offer information on CURE Apr 21 2024 102 Put contract for CURE.
WebMar 25, 2024 · Vancouver, British Columbia--(Newsfile Corp. - March 25, 2024) - Biocure Technology Inc. (CSE: CURE) (OTCQB: BICTF) ("Biocure" or the "Company") is pleased to provide the following operational and ... WebThe Company. Biocure Technology Inc. is a biopharmaceutical company comprised of leading scientists specializing in the development and commercialization of its own CAR T-cell therapy, targeting Chronic lymphocytic leukemia and solid tumor cancers. Additionally, the Company is developing Biosimilar technologies for cancer treatment.
WebBiocure Technology Inc. is a biopharmaceutical company comprised of leading scientists specializing in the development and commercialization of its own CAR T-cell therapy, … WebJul 15, 2024 · Vancouver, British Columbia--(Newsfile Corp. - August 3, 2024) - BioCure Technology Inc. (CSE: CURE) (OTCQB: BICTF) (FSE: 1WH ) (CURE or the Company) - BioCure Technology Inc. ("BioCure" or the "Company") is pleased to announce listing on the Frankfurt Stock Exchange as of August 2, 2024 and the completion of an issuer …
WebBiocure Technology Inc. is a biopharmaceutical company comprised of leading scientists specializing in the development and commercialization of its own CAR T-cell therapy, targeting Chronic lymphocytic leukemia and solid tumor cancers. Additionally, the Company is developing Biosimilar technologies for cancer treatment.
WebBIOCURE TECHNOLOGY INC. : Stock quote, stock chart, quotes, analysis, advice, financials and news for share BIOCURE TECHNOLOGY INC. Other OTC: BICTF Other OTC marci rossell blogWebCompany profile page for Biocure Technology Inc including stock price, company news, press releases, executives, board members, and contact information csl registerWebJul 22, 2024 · About Biocure. Biocure is a leading biotech company developing its CAR-T cell therapy for leukemia, lung, breast and pancreatic cancer. Biocure, headquartered in … marci salmonWebExperience true High Definition video unlike any other system as your monitor brings everything to life. The DVR finally brings 4K UHD quality to a NVR that can be viewed on … marci santiagoWebMar 26, 2024 · Biocure Technology Inc., together with its subsidiary, engages in developing and commercializing biopharmaceutical technologies for use in recombinant and ranibizumab. The company is developing Interferons-ß for the treatment of multiple sclerosis; Ranibizumab, a monoclonal antibody fragment for the treatment of macular … marci rizzoWebbiocure announced a breakthrough pre-clinical trial results for car-t cells treatment of acute leukemia Trial results demonstrated zero toxicity of the reengineered BioCure CAR-T … Biocure Technology Inc. is a biopharmaceutical company comprised … The Board of Directors of Biocure Technology Inc. (the “Company”) sets … VANCOUVER, British Columbia, February 8, 2024 -- Biocure Technology Inc. … marci samponWebJul 15, 2024 · BioCure Technology Inc. announces that it has successfully closed a non-brokered private placement consisting of 6,706,525 Units at a price of $0.16 cents per Unit for gross proceeds of $1,073,044 ... marci roland